Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects

Cancer stem cells (CSCs) with their self-renewal ability are accepted as cells which initiate tumors. CSCs are regarded as interesting targets for novel anticancer therapeutic agents because of their association with tumor recurrence and resistance to conventional therapies, including radiotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Masoumi, Javad, Jafarzadeh, Abdollah, Abdolalizadeh, Jalal, Khan, Haroon, Philippe, Jeandet, Mirzaei, Hamed, Mirzaei, Hamid Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343118/
https://www.ncbi.nlm.nih.gov/pubmed/34386318
http://dx.doi.org/10.1016/j.apsb.2020.12.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343118/
https://www.ncbi.nlm.nih.gov/pubmed/34386318
http://dx.doi.org/10.1016/j.apsb.2020.12.015

Ejemplares similares